188 related articles for article (PubMed ID: 11332036)
1. Interaction between photodynamic therapy and BCG immunotherapy responsible for the reduced recurrence of treated mouse tumors.
Korbelik M; Sun J; Posakony JJ
Photochem Photobiol; 2001 Apr; 73(4):403-9. PubMed ID: 11332036
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of tumour response to photodynamic therapy by adjuvant mycobacterium cell-wall treatment.
Korbelik M; Cecic I
J Photochem Photobiol B; 1998 Jul; 44(2):151-8. PubMed ID: 9757597
[TBL] [Abstract][Full Text] [Related]
3. Induction of systemic neutrophil response in mice by photodynamic therapy of solid tumors.
Cecic I; Parkins CS; Korbelik M
Photochem Photobiol; 2001 Nov; 74(5):712-20. PubMed ID: 11723800
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic activity of lutetium-texaphyrin in a mouse tumor system.
Hammer-Wilson MJ; Ghahramanlou M; Berns MW
Lasers Surg Med; 1999; 24(4):276-84. PubMed ID: 10327046
[TBL] [Abstract][Full Text] [Related]
5. The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy.
Korbelik M; Krosl G; Krosl J; Dougherty GJ
Cancer Res; 1996 Dec; 56(24):5647-52. PubMed ID: 8971170
[TBL] [Abstract][Full Text] [Related]
6. High-resolution PET imaging for in vivo monitoring of tumor response after photodynamic therapy in mice.
Lapointe D; Brasseur N; Cadorette J; La Madeleine C; Rodrigue S; van Lier JE; Lecomte R
J Nucl Med; 1999 May; 40(5):876-82. PubMed ID: 10319764
[TBL] [Abstract][Full Text] [Related]
7. Hyperoxygenation enhances the tumor cell killing of photofrin-mediated photodynamic therapy.
Huang Z; Chen Q; Shakil A; Chen H; Beckers J; Shapiro H; Hetzel FW
Photochem Photobiol; 2003 Nov; 78(5):496-502. PubMed ID: 14653582
[TBL] [Abstract][Full Text] [Related]
8. Exploitation of immune response-eliciting properties of hypocrellin photosensitizer SL052-based photodynamic therapy for eradication of malignant tumors.
Korbelik M; Merchant S; Huang N
Photochem Photobiol; 2009; 85(6):1418-24. PubMed ID: 19709384
[TBL] [Abstract][Full Text] [Related]
9. Enzyme-activatable imaging probe reveals enhanced neutrophil elastase activity in tumors following photodynamic therapy.
Mitra S; Modi KD; Foster TH
J Biomed Opt; 2013 Oct; 18(10):101314. PubMed ID: 23897439
[TBL] [Abstract][Full Text] [Related]
10. In vivo photodynamic therapy with the new near-IR absorbing water soluble photosensitizer lutetium texaphyrin and a high intensity pulsed light delivery system.
Kostenich G; Orenstein A; Roitman L; Malik Z; Ehrenberg B
J Photochem Photobiol B; 1997 May; 39(1):36-42. PubMed ID: 9210320
[TBL] [Abstract][Full Text] [Related]
11. Molecular determinants of photodynamic therapy for lung cancers.
Usuda J; Ichinose S; Ishizumi T; Ohtani K; Inoue T; Maehara S; Imai K; Shima K; Ohira T; Kato H; Ikeda N
Lasers Surg Med; 2011 Sep; 43(7):591-9. PubMed ID: 22057486
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of photodynamic therapy for recurrent, high grade nonmuscle invasive bladder cancer refractory or intolerant to bacille Calmette-Guérin immunotherapy.
Lee JY; Diaz RR; Cho KS; Lim MS; Chung JS; Kim WT; Ham WS; Choi YD
J Urol; 2013 Oct; 190(4):1192-9. PubMed ID: 23648222
[TBL] [Abstract][Full Text] [Related]
13. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow.
Chan WS; Brasseur N; La Madeleine C; van Lier JE
Anticancer Res; 1996; 16(4A):1887-92. PubMed ID: 8712717
[TBL] [Abstract][Full Text] [Related]
14. Effects of photodynamic therapy on adhesion molecules and metastasis.
Rousset N; Vonarx V; Eléouet S; Carré J; Kerninon E; Lajat Y; Patrice T
J Photochem Photobiol B; 1999; 52(1-3):65-73. PubMed ID: 10643074
[TBL] [Abstract][Full Text] [Related]
15. Treatment of superficial bladder tumors: achievements and needs. The EORTC Genitourinary Group.
Kurth KH; Bouffioux C; Sylvester R; van der Meijden AP; Oosterlinck W; Brausi M
Eur Urol; 2000; 37 Suppl 3():1-9. PubMed ID: 10828681
[TBL] [Abstract][Full Text] [Related]
16. Pro-apoptotic and anti-inflammatory properties of the green tea constituent epigallocatechin gallate increase photodynamic therapy responsiveness.
Ferrario A; Luna M; Rucker N; Wong S; Gomer CJ
Lasers Surg Med; 2011 Sep; 43(7):644-50. PubMed ID: 22057492
[TBL] [Abstract][Full Text] [Related]
17. [BCG versus photodynamic therapy (PDT) for nonmuscle invasive bladder cancer-a multicentre clinical phase III study].
Jocham D; von Wietersheim J; Pflüger H; Steiner H; Doehn C; Büttner H; Böhle A; Kausch I
Aktuelle Urol; 2009 Mar; 40(2):91-9. PubMed ID: 19214951
[TBL] [Abstract][Full Text] [Related]
18. Effects of photodynamic therapy in combination with intravesical drugs in a murine bladder tumor model.
Cho YH; Straight RC; Smith JA
J Urol; 1992 Mar; 147(3):743-6. PubMed ID: 1538475
[TBL] [Abstract][Full Text] [Related]
19. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
[TBL] [Abstract][Full Text] [Related]
20. Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma.
Ferrario A; von Tiehl KF; Rucker N; Schwarz MA; Gill PS; Gomer CJ
Cancer Res; 2000 Aug; 60(15):4066-9. PubMed ID: 10945611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
